找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Disease Recurrence After Liver Transplantation; Natural History, Tre Paul J. Thuluvath Book 2016 Springer Science+Business Media New York 2

[復(fù)制鏈接]
樓主: otitis-externa
41#
發(fā)表于 2025-3-28 16:52:23 | 只看該作者
Treatment of Recurrent Hepatitis C,is B. The predominant reason for the lower survival rate of people who have hepatitis C infection is HCV recurrence leading to cirrhosis and liver failure. In liver transplant recipients, fibrosis progresses at an accelerated rate, resulting in cirrhosis in 30 % of transplant recipients within 5 yea
42#
發(fā)表于 2025-3-28 21:23:27 | 只看該作者
Recurrence of Autoimmune Hepatitis After Liver Transplantation,e diagnosis, the reported incidence varies but recurrence may occur in around one third of patients at a median time of around 2–3 years but may occur as late as 10 years after transplant. Treatment of recurrent disease with the addition or increase in corticosteroids is often successful, although l
43#
發(fā)表于 2025-3-29 01:23:36 | 只看該作者
Alcoholic Cirrhosis, Transplantation, and Recurrence of Disease,f alcoholism and recidivism have challenged absolute approaches to define periods of pretransplant sobriety, but may further complicate recurrence of any alcohol use post-transplant. Rates of recidivism are reported at approximately 30 %, but recurrent disease leading to allograft damage is limited
44#
發(fā)表于 2025-3-29 04:32:46 | 只看該作者
45#
發(fā)表于 2025-3-29 10:41:13 | 只看該作者
46#
發(fā)表于 2025-3-29 12:32:35 | 只看該作者
Nonalcoholic Fatty Liver Disease Post-Liver Transplantation, cause of chronic liver disease and cirrhosis or liver cancer secondary to fatty liver disease may become the most common indication for liver transplantation in the Western world in the near future. Recurrence of fatty liver disease following liver transplantation is not unusual—leading at least in
47#
發(fā)表于 2025-3-29 16:55:53 | 只看該作者
48#
發(fā)表于 2025-3-29 19:44:01 | 只看該作者
Recurrence of HCC When Transplanted Outside Milan Criteria,over half a million new cases diagnosed annually. It is presently the second leading cause of cancer-related mortality in the world; the disease burden is highest in Eastern Asian and in sub-Saharan areas with endemic HBV infection. With respect to any available treatment for liver cancer, liver tra
49#
發(fā)表于 2025-3-30 01:17:08 | 只看該作者
Role of Neoadjuvant and Adjuvant Treatment in HCC Recurrence After Liver Transplantation,directed therapy before LT has been used as a bridging therapy and as a down-staging method for patients with intermediate HCC. Transarterial chemoembolization (TACE) and radiofrequency ablation are effective treatments that can down-stage intermediate staged HCC to fulfill Milan criteria for LT. Ne
50#
發(fā)表于 2025-3-30 06:36:58 | 只看該作者
Cholangiocarcinoma, with incidental tumors found at the time of transplant, due to early recurrence of tumors and mortality related to recurrent cancer. Recurrent tumors are found as adenopathy or in distant sites such as bone, lungs, or in the liver allograft. De novo cholangiocarcinoma can occur after LTX in the bil
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 07:25
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
醴陵市| 巴中市| 安顺市| 荥阳市| 乌兰察布市| 连州市| 舒城县| 墨竹工卡县| 肥西县| 石渠县| 房产| 合肥市| 武城县| 秭归县| 新邵县| 嘉义县| 宣城市| 枣阳市| 伊川县| 临海市| 嘉荫县| 东乌珠穆沁旗| 扶绥县| 壤塘县| 开平市| 青浦区| 河西区| 讷河市| 天津市| 隆化县| 五台县| 盐池县| 孟津县| 南木林县| 南平市| 砚山县| 涡阳县| 犍为县| 准格尔旗| 汉源县| 呈贡县|